Delivery Order SPE2DB24D2101-SPE2DB24FKFJV
Award Date
7/22/24
Potential Completion Date
8/12/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medication, with a ceiling value of $13,953.30 and a performance period ending on May 21, 2025. This contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $4,651.10. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 16, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product, with a ceiling value of $34,883.25 and a completion date of April 3, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $4,651.10 and a completion date of July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,197.41, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $6,976.65 and a performance period through May 2025. The contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $13,953.30 and a period of performance through March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a Delivery Order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with a ceiling value of $18,604.40 and a period of performance ending on June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a ceiling value of $13,953.30 and a period of performance through June 26, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $2,197.41 firm fixed price delivery order is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...